TCEA3 binds to TGF-beta receptor I and induces Smad-independent, JNK-dependent apoptosis in ovarian cancer cells.

TFIIS is a transcription elongation factor conserved in frog, mouse and human. Recently, knockdown of TCEA1, the most well-characterized isoform of TFIIS, by RNA silencing was reported to inhibit cancer cell proliferation and induce apoptosis in breast, lung and pancreatic cancer cell lines through activation of p53 (Hubbard et al., 2008 [1]). However, the functions of other TFIIS isoforms are poorly defined. The present study shows that TCEA3, an isoform of TFIIS, can trigger ovarian cancer-specific cell death by activating the JNK signaling pathway. TCEA3 expression is low in ovarian cancer cell lines compared to noncancerous ovarian epithelial cells. Suppression of TCEA3 in noncancerous ovarian epithelial cells promotes cell growth whereas ectopic expression of TCEA3 in ovarian cancer cell lines induces the caspase-dependent mitochondrial cell death pathway. Molecular and chemical inhibition assays show that the interaction of TCEA3 with TGFβ receptor I induces cell death in ovarian cancer cell through Smad-independent activation of the JNK pathway. These results reveal that TCEA3 induces a novel apoptotic mechanism in OEC, which provides TCEA3 as a novel target to develop therapeutics of ovarian cancer.

[1]  C. Heldin,et al.  Non-Smad TGF-β signals , 2005, Journal of Cell Science.

[2]  J. Massagué,et al.  Smad transcription factors. , 2005, Genes & development.

[3]  A. Schier,et al.  Nodal signalling in vertebrate development , 2000, Nature.

[4]  D. Reines,et al.  Transcription elongation factor SII , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[5]  Rebecca L. Jones,et al.  TGF-β superfamily expression and actions in the endometrium and placenta , 2006 .

[6]  L. Hartmann,et al.  Current management strategies for ovarian cancer. , 2007, Mayo Clinic proceedings.

[7]  R. Conaway,et al.  The RNA polymerase II general elongation factors. , 1996, Trends in biochemical sciences.

[8]  S. Pecorelli,et al.  Cancer in Women , 1963 .

[9]  Ikuo Konishi,et al.  Epigenetic suppression of the TGF-beta pathway revealed by transcriptome profiling in ovarian cancer. , 2011, Genome research.

[10]  W. Earnshaw,et al.  Caspase‐6 gene disruption reveals a requirement for lamin A cleavage in apoptotic chromatin condensation , 2002, The EMBO journal.

[11]  J. Massagué,et al.  TGFβ in Cancer , 2008, Cell.

[12]  C. Arteaga.  Inhibition of TGFβ signaling in cancer therapy , 2006 .

[13]  R. Derynck,et al.  SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS , 2005 .

[14]  J. Seoane.  The TGFß pathway as a therapeutic target in cancer , 2008 .

[15]  C. Kane,et al.  Genomic characterization of a testis-specific TFIIS (TCEA2) gene. , 1997, Genomics.

[16]  C. Heldin,et al.  The type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner , 2008, Nature Cell Biology.

[17]  Lorenzo Galluzzi,et al.  Mitochondrial membrane permeabilization in cell death. , 2007, Physiological reviews.

[18]  Ying E. Zhang,et al.  Smad-dependent and Smad-independent pathways in TGF-β family signalling , 2003, Nature.

[19]  M. Yamashita,et al.  TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta. , 2008, Molecular cell.

[20]  A. Godwin,et al.  The biology of ovarian cancer development , 2010, Cancer.

[21]  A. Jemal,et al.  Cancer Statistics, 2005 , 2005, CA: a cancer journal for clinicians.

[22]  G. Kroemer,et al.  Lysosomal membrane permeabilization in cell death , 2008, Oncogene.

[23]  P. Wingo,et al.  Cancer statistics, 1997 , 1997, CA: a cancer journal for clinicians.

[24]  R. Puri,et al.  Knockdown of TFIIS by RNA silencing inhibits cancer cell proliferation and induces apoptosis , 2008, BMC Cancer.

[25]  Colin Adrain,et al.  Executioner Caspase-3, -6, and -7 Perform Distinct, Non-redundant Roles during the Demolition Phase of Apoptosis* , 2001, The Journal of Biological Chemistry.

[26]  R. Akhurst.  Large- and small-molecule inhibitors of transforming growth factor-beta signaling. , 2006, Current opinion in investigational drugs.

[27]  B. Tsang,et al.  Nodal induces apoptosis and inhibits proliferation in human epithelial ovarian cancer cells via activin receptor-like kinase 7. , 2004, The Journal of clinical endocrinology and metabolism.